Morphic Holding, Inc.
NASDAQ: MORF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Praveen P. Tipirneni
- Employees
- 128
- Headquarters
- Waltham, United States
- IPO year
- 2019
- Market cap
- $2.9B
- Website
- https://www.morphictx.com
Loading MORF…
Loading profile data…Frequently asked questions about MORF
What does Morphic Holding, Inc. (MORF) do?
Morphic Holding, Inc. is a biopharmaceutical company dedicated to the discovery and advancement of oral, small-molecule integrin-based therapies. These treatments are designed to address a broad spectrum of conditions, including autoimmune, cardiovascular, and metabolic diseases, as well as various forms of fibrosis and cancer. The company's pri...
Where does MORF trade?
Morphic Holding, Inc. (MORF) trades on the NASDAQ Global Market.
What sector is MORF in?
Morphic Holding, Inc. (MORF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Morphic Holding, Inc.?
Praveen P. Tipirneni is the chief executive officer of Morphic Holding, Inc. (MORF).
Where is Morphic Holding, Inc. headquartered?
Morphic Holding, Inc. is headquartered in United States.
Does MORF pay a dividend?
Morphic Holding, Inc. (MORF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MORF go public?
Morphic Holding, Inc. (MORF) completed its initial public offering in 2019.